Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Daiichi Sankyo to enter Japan's generic drug market
Reuters
Friday, February 26, 2010 - 10:49am
tags:
Japan, generics, Daiichi Sankyo
Drug stocks inch higher; Cleveland BioLabs sinks
Marketwatch
Friday, February 26, 2010 - 10:41am
tags:
drug stocks, Cleveland BioLabs
Biovail set to hire reps for new U.S. force
Fierce Pharma
Friday, February 26, 2010 - 10:33am
tags:
Biovail, sales reps
Top 20 Biotech Venture Capital Deals of 2009
Fierce Biotech
Friday, February 26, 2010 - 9:47am
tags:
biotech, venture capital
What Investors Think About ImmunoGen
Motley Fool
Friday, February 26, 2010 - 9:27am
tags:
Immunogen
13 Is Pfizer's Lucky Number
Motley Fool
Friday, February 26, 2010 - 9:24am
tags:
Prevnar 13, Pfizer, vaccines
Glaxo Loses Bid To Preempt Paxil Lawsuit
Pharmalot
Friday, February 26, 2010 - 9:23am
tags:
GSK, lawsuits, Paxil
Biotech Stock Mailbag: BioSante Pharma
TheStreet.com
Friday, February 26, 2010 - 9:20am
tags:
BioSante, Proctor & Gamble, Novelos Therapeutics, InterMune, ARYx, Health Discovery, Xoma
AVANIR Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Friday, February 26, 2010 - 8:33am
tags:
Avanir
Amylin Pharmaceuticals May Have a Great Shot
Barron's
Friday, February 26, 2010 - 8:31am
tags:
Amylin, exanitide
Merck Puts Up Its Asset-Sale Shingle
InVivo
Friday, February 26, 2010 - 8:27am
tags:
Merck, licensing
Ranbaxy Shares Fall on Earnings Forecast, FDA Issues
Bloomberg
Friday, February 26, 2010 - 8:26am
tags:
Ranbaxy, earnings
WuXi Pharma COO Highlights Planned Growth
Seeking Alpha
Friday, February 26, 2010 - 8:23am
tags:
China, WuXi PharmaTech
Glaxo Strikes Back at Drug Critics, But It's a Big Swing... and a Miss
BNET Pharma
Thursday, February 25, 2010 - 4:18pm
tags:
GSK, Avandia
Pfizer Experimental Bone Drug Shows Mixed Results In Study
WSJ Online
Thursday, February 25, 2010 - 4:15pm
tags:
Pfizer, Fablyn
FDA says Bristol-Myers kidney transplant drug extends life, but carries side effects
Yahoo/AP
Thursday, February 25, 2010 - 4:15pm
tags:
FDA, kidney transplant, Bristol-Myers Squibb
These Drugs Generated Most Adverse Event Reports
Pharmalot
Thursday, February 25, 2010 - 10:13am
tags:
adverse events
Adolor narrows 4Q loss as Entereg sales increase
Yahoo/AP
Thursday, February 25, 2010 - 10:12am
tags:
Adolor, earnings, Entereg
HGSI Pipeline Bigger than Earnings
Yahoo/Zacks.com
Thursday, February 25, 2010 - 10:11am
tags:
Human Genome Sciences, earnings, Novartis, GSK
Aveo Pharma ups targeted range for IPO
Bizjournals.com
Thursday, February 25, 2010 - 10:10am
tags:
Aveo Pharmaceutical, IPOs, cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.